ANI Pharmaceuticals Inc. (ANIP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ANI Pharmaceuticals Inc.

    NASDAQ: ANIP · Real-Time Price · USD
    96.00
    1.08 (1.14%)
    At close: Sep 04, 2025, 3:59 PM
    96.41
    0.43%
    Pre-market: Sep 05, 2025, 06:58 AM EDT

    ANI Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 614.38M 486.82M 316.38M 216.14M
    Cost of Revenue
    		 250.21M 181.51M 138.78M 100.61M
    Gross Profit
    		 364.17M 305.3M 177.6M 115.53M
    Operating Income
    		 584K 46.97M -35.28M -39.79M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -22.21M 19.87M -62.66M -56.06M
    Net Income
    		 -18.52M 18.78M -47.9M -42.6M
    Selling & General & Admin
    		 249.64M 161.7M 124.04M 84.29M
    Research & Development
    		 44.58M 34.29M 22.32M 11.37M
    Other Expenses
    		 69.36M 62.35M 56.97M 59.66M
    Operating Expenses
    		 363.58M 258.33M 203.33M 155.32M
    Interest Expense
    		 17.6M 26.94M 28.05M 11.92M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 613.79M 439.85M 351.67M 255.93M
    Income Tax Expense
    		 -3.69M 1.09M -14.77M -13.46M
    Shares Outstanding (Basic)
    		 19.32M 18M 16.26M 12.6M
    Shares Outstanding (Diluted)
    		 19.32M 18.19M 16.26M 12.6M
    EPS (Basic)
    		 -1.04 0.95 -3.05 -3.4
    EPS (Diluted)
    		 -1.04 0.94 -3.05 -3.4
    EBITDA
    		 79.15M 106.6M 33.92M -1.68M
    EBIT
    		 11.42M 46.81M -36.91M -48.94M
    Depreciation & Amortization
    		 67.73M 59.79M 59.65M 47.25M

    Add to Watchlist